Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Sabra Healthcare REIT, Inc. SBRA

Growth Flags show if company had growth for consecutive years

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.
An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.
Dec '25
Dec '24
Dec '23
Dec '22
Dec '21
Dec '20
Dec '19
Dec '18
Dec '17
Dec '16
Revenue
774.63
703.24
647.51
624.81
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Revenue Growth
10.15%
8.61%
3.63%
9.70%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Gross Profit
774.63
703.24
647.51
624.81
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
SG&A Expenses
53.71
50.07
47.47
39.57
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Operating Income
256.55
238.56
207.19
140.66
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Non-operating Income/Expense
(103.13)
(110.44)
(188.53)
(118.99)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Non-operating Interest Expenses
112.49
115.27
112.96
105.47
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Investment Gain/Loss (Other)
3.93
(0.40)
(2.90)
(98.03)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBT
153.42
128.11
18.66
21.67
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Income Tax Provision
1.84
1.01
2.00
1.24
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Income after Tax
151.58
127.11
16.65
20.43
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Dividends (Preferred)
‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Non-Controlling Interest
(0.10)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Income Common
155.61
126.71
13.76
(77.60)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Basic)
0.64
0.54
0.06
(0.34)
‡‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡
‡‡‡‡
EPS (Diluted)
0.64
0.54
0.06
(0.34)
‡‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡‡
‡‡‡
‡‡‡‡
Shares (Basic, Weighted)
241.31
233.50
231.20
230.95
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Shares (Diluted, Weighted)
244.50
236.05
232.79
230.95
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Gross Margin
100.00%
100.00%
100.00%
100.00%
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
EBIT Margin
33.12%
33.92%
32.00%
22.51%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBT margin
19.81%
18.22%
2.88%
3.47%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Profit Margin
20.09%
18.02%
2.12%
(12.42%)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Free Cash Flow Margin
(7.38%)
30.63%
59.43%
41.03%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBITDA
443.54
408.18
390.27
328.44
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBIT
256.55
238.56
207.19
140.66
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Income from Continuous Operations
155.51
126.71
13.76
(77.60)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Consolidated Net Income/Loss
155.51
126.71
13.76
(77.60)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Basic, from Continuous Ops)
0.64
0.54
0.06
(0.34)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Basic, Consolidated)
0.64
0.54
0.06
(0.34)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Diluted, from Cont. Ops)
0.64
0.54
0.06
(0.34)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Shares (Diluted, Average)
244.50
236.05
232.79
230.95
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EPS (Diluted, Consolidated)
0.64
0.54
0.06
(0.34)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EBITDA Margin
57.26%
58.04%
60.27%
52.57%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
Operating Cash Flow Margin
45.00%
44.16%
46.42%
50.53%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us